Literature DB >> 31532535

Mechanisms by Which Obesity Impacts Survival from Acute Lymphoblastic Leukemia.

Etan Orgel1, Jessica L Sea2, Steven D Mittelman2.   

Abstract

The prevalence of obesity has steadily risen over the past decades, even doubling in more than 70 countries. High levels of body fat (adiposity) and obesity are associated with endocrine and hormonal dysregulation, cardiovascular compromise, hepatic dysfunction, pancreatitis, changes in drug metabolism and clearance, inflammation, and metabolic stress. It is thus unsurprising that obesity can affect the development of and survival from a wide variety of malignancies. This review focuses on acute lymphoblastic leukemia, the most common malignancy in children, to explore the multiple mechanisms connecting acute lymphoblastic leukemia, obesity, and adipocytes, and the implications for leukemia therapy.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 31532535      PMCID: PMC6750167          DOI: 10.1093/jncimonographs/lgz020

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  64 in total

1.  The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.

Authors:  Mars B van't Veer; Anne M Brooijmans; Anton W Langerak; Brenda Verhaaf; Chantal S Goudswaard; Wilfried J Graveland; Kirsten van Lom; Peter J M Valk
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

2.  Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia.

Authors:  Nobuko Hijiya; John C Panetta; Yinmei Zhou; Emily P Kyzer; Scott C Howard; Sima Jeha; Bassem I Razzouk; Raul C Ribeiro; Jeffrey E Rubnitz; Melissa M Hudson; John T Sandlund; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

3.  Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia.

Authors:  J M Boag; A H Beesley; M J Firth; J R Freitas; J Ford; K Hoffmann; A J Cummings; N H de Klerk; U R Kees
Journal:  Leukemia       Date:  2006-08-31       Impact factor: 11.528

4.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.

Authors:  T Yokota; K Oritani; I Takahashi; J Ishikawa; A Matsuyama; N Ouchi; S Kihara; T Funahashi; A J Tenner; Y Tomiyama; Y Matsuzawa
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism.

Authors:  J A McCubrey; L S Steelman; M W Mayo; P A Algate; R A Dellow; M Kaleko
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia.

Authors:  Ellis Groninger; Tiny Meeuwsen-de Boar; Pauline Koopmans; Donald Uges; Wim Sluiter; Anjo Veerman; Willem Kamps; Siebold de Graaf
Journal:  Pediatr Res       Date:  2002-07       Impact factor: 3.756

9.  Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.

Authors:  Mary Ann Weiser; Maria E Cabanillas; Marina Konopleva; Deborah A Thomas; Sherry A Pierce; Carmen P Escalante; Hagop M Kantarjian; Susan M O'Brien
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

Review 10.  Leptin receptor and leukemia.

Authors:  M Hino; T Nakao; T Yamane; K Ohta; T Takubo; N Tatsumi
Journal:  Leuk Lymphoma       Date:  2000-02
View more
  5 in total

1.  Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia.

Authors:  Steven D Mittelman; Jiyoon Kim; Gordana Raca; Gang Li; Matthew J Oberley; Etan Orgel
Journal:  Blood       Date:  2021-07-15       Impact factor: 25.476

2.  Prognostic Observational Analysis of BMI, Leptin, and Adiponectin in Children With Acute Lymphocytic Leukemia Undergoing Remission-Induction Chemotherapy.

Authors:  Jing Sun; Ru Zhang; Jianjun Tang; Xuedong Wu; Lu Zhu; Haiying Huang; Huimin Chen; Minhua Xiao; Hongfeng Luo; Haiqing Zheng; Jiaqi Chen
Journal:  Front Pediatr       Date:  2022-03-21       Impact factor: 3.418

3.  The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030.

Authors:  Mengbao Du; Weiwei Chen; Ke Liu; Limengmeng Wang; Yihan Hu; Yingying Mao; Xiaohui Sun; Yi Luo; Jimin Shi; Keding Shao; He Huang; Ding Ye
Journal:  J Oncol       Date:  2022-04-25       Impact factor: 4.501

4.  Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial.

Authors:  Etan Orgel; Celia Framson; Rubi Buxton; Jiyoon Kim; Gang Li; Jonathan Tucci; David R Freyer; Weili Sun; Matthew J Oberley; Christina Dieli-Conwright; Steven D Mittelman
Journal:  Blood Adv       Date:  2021-04-13

5.  Global burden and trend of acute lymphoblastic leukemia from 1990 to 2017.

Authors:  Ming Yi; Linghui Zhou; Anping Li; Suxia Luo; Kongming Wu
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.